Martin Roessner

3.9k total citations · 1 hit paper
11 papers, 2.9k citations indexed

About

Martin Roessner is a scholar working on Pulmonary and Respiratory Medicine, Statistics and Probability and Economics and Econometrics. According to data from OpenAlex, Martin Roessner has authored 11 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Statistics and Probability and 3 papers in Economics and Econometrics. Recurrent topics in Martin Roessner's work include Statistical Methods in Clinical Trials (4 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Prostate Cancer Treatment and Research (3 papers). Martin Roessner is often cited by papers focused on Statistical Methods in Clinical Trials (4 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Prostate Cancer Treatment and Research (3 papers). Martin Roessner collaborates with scholars based in United States, Canada and France. Martin Roessner's co-authors include Mustafa Özgüroğlu, Sunil Gupta, Jean-Pascal Machiels, Mary J. MacKenzie, Johann S. de Bono, Steinbjørn Hansen, Gwénaëlle Gravis, I. Bodrogi, Liji Shen and Stéphane Oudard and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Martin Roessner

10 papers receiving 2.8k citations

Hit Papers

Prednisone plus cabazitaxel or mitoxantrone for metastati... 2010 2026 2015 2020 2010 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
    2010 2.4k citations Johann S. de Bono, Stéphane Oudard et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Roessner United States 8 2.2k 961 897 695 511 11 2.9k
Liji Shen United States 16 2.8k 1.3× 1.3k 1.3× 1.1k 1.2× 946 1.4× 620 1.2× 37 3.5k
Ivo Kocák Czechia 13 2.5k 1.1× 1.4k 1.4× 937 1.0× 798 1.1× 724 1.4× 41 3.3k
Peter De Porre United States 26 2.5k 1.1× 761 0.8× 893 1.0× 854 1.2× 730 1.4× 91 3.4k
Luis Fein Argentina 18 2.6k 1.2× 1.7k 1.7× 727 0.8× 1.3k 1.9× 530 1.0× 52 3.8k
Russell Z. Szmulewitz United States 25 2.0k 0.9× 888 0.9× 554 0.6× 756 1.1× 829 1.6× 121 2.9k
David Lorente Spain 28 1.8k 0.8× 1.2k 1.2× 653 0.7× 1.1k 1.5× 594 1.2× 100 2.9k
Bryan Selby United States 5 3.3k 1.5× 917 1.0× 1.1k 1.2× 1.0k 1.5× 848 1.7× 11 3.7k
Stephen D. Rubin United States 13 1.3k 0.6× 2.6k 2.8× 811 0.9× 673 1.0× 1.1k 2.2× 17 4.0k
Simon Chowdhury United Kingdom 29 4.0k 1.8× 1.4k 1.4× 1.3k 1.5× 1.4k 2.0× 1.0k 2.0× 199 5.1k
Michael T. Schweizer United States 33 2.2k 1.0× 1.1k 1.1× 444 0.5× 746 1.1× 929 1.8× 144 3.1k

Countries citing papers authored by Martin Roessner

Since Specialization
Citations

This map shows the geographic impact of Martin Roessner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Roessner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Roessner more than expected).

Fields of papers citing papers by Martin Roessner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Roessner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Roessner. The network helps show where Martin Roessner may publish in the future.

Co-authorship network of co-authors of Martin Roessner

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Roessner. A scholar is included among the top collaborators of Martin Roessner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Roessner. Martin Roessner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Bexon, Martin, Nicholas Butowski, Chandtip Chandhasin, et al.. (2021). CLRM-09. INCORPORATING EXTERNAL CONTROL ARM IN MDNA55 RECURRENT GLIOBLASTOMA REGISTRATION TRIAL. Neuro-Oncology Advances. 3(Supplement_4). iv3–iv3. 3 indexed citations
2.
3.
Bono, Johann S. de, Stéphane Oudard, Mustafa Özgüroğlu, et al.. (2010). Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial. The Lancet. 376(9747). 1147–1154. 2397 indexed citations breakdown →
4.
Quan, Hui, et al.. (2009). Sample size considerations for Japanese patients in a multi‐regional trial based on MHLW guidance. Pharmaceutical Statistics. 9(2). 100–112. 61 indexed citations
5.
Posner, Marshall R., Charles M. Norris, Lori J. Wirth, et al.. (2009). Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation. Annals of Oncology. 20(5). 921–927. 102 indexed citations
6.
Shun, Zhenming, et al.. (2009). A Unified Approach to Flexible Sample Size Design with Realistic Constraints. Statistics in Biopharmaceutical Research. 1(4). 388–398.
7.
8.
9.
Labs, Karl‐Heinz, Mark R. Nehler, Martin Roessner, Kurt A. Jaeger, & William R. Hiatt. (1999). Reliability of treadmill testing in peripheral arterial disease: a comparison of a constant load with a graded load treadmill protocol. Vascular Medicine. 4(4). 239–246. 53 indexed citations
10.
Whitehouse, Peter J., Barbara Kittner, Martin Roessner, et al.. (1998). Clinical Trial Designs for Demonstrating Disease-Course-Altering Effects in Dementia. Alzheimer Disease & Associated Disorders. 12(4). 281–294. 33 indexed citations
11.
Rother, M., Timo Erkinjuntti, Martin Roessner, et al.. (1998). Propentofylline in the Treatment of Alzheimer’s Disease and Vascular Dementia: A Review of Phase III Trials. Dementia and Geriatric Cognitive Disorders. 9(Suppl. 1). 36–43. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liji Shen Breakdown of academic impact, for papers by Ivo Kocák Breakdown of academic impact, for papers by Peter De Porre Breakdown of academic impact, for papers by Luis Fein Breakdown of academic impact, for papers by Russell Z. Szmulewitz Breakdown of academic impact, for papers by David Lorente Breakdown of academic impact, for papers by Bryan Selby Breakdown of academic impact, for papers by Stephen D. Rubin Breakdown of academic impact, for papers by Simon Chowdhury Breakdown of academic impact, for papers by Michael T. Schweizer
Rankless by CCL
2026